Stanford's George Lundberg introduces a new kind of cancer research and information hub in The Scientist this week. Called Cancer Commons, the new platform adds the patient to the publishing equation, in order to advance the way cancer is treated and the way therapies are developed. It blends scientific publishing with social media in "a hub of open-science communities in which physicians, patients, and scientists collaborate on models of cancer subtypes to more accurately predict individual responses to therapy," Lundberg says. The platform's developers are creating molecular disease models for various kinds of cancer, starting with melanoma. They'll match patients with the best individualized treatments based on genomic information and record and disseminate outcomes to the research community, he adds. Subtypes and therapies will be revised based on new information and research. The platform will also include information that's been peer-reviewed, but deemed not ready for prime time in the hopes that it might be helpful to late-stage cancer patients.
A New Kind of Cancer 'Hub'
Apr 21, 2011